Context Lung diseases are an increasing cause of morbidity and mortality worldwide. Every year, approximately 10 million new cases of tuberculosis (TB) are recorded, resulting in approx.1.5 million deaths. (Multi-) drug-resistant strains further complicate global TB control and challenge the WHO’s goal to end the TB epidemic by 2030. Moreover,…
Context The availability, safety and quality of blood and blood products is an essential component of any health care system. The WHO has therefore listed them as essential medicines. Blood products are life-saving for many patients, in particular for women with pregnancy-related complications, children suffering from severe anaemia and people…
Context Vaccines remain the most effective tool for preventing infectious diseases and for improving global health. As only 1% of the vaccines needed in Africa are currently produced in Africa, the continent needs a robust vaccine industry. The COVID-19 pandemic, in particular, has highlighted the need for supranational structures to…
Context The Ebola epidemic and the COVID-19 pandemic have clearly demonstrated that timely access to safe, effective and affordable medicines and vaccines is vital to prevent and fight infectious diseases and protect public health. Many African countries, however, rely on imports of vaccines because national production capacity is insufficient and…
Context Despite significant progress in immunisation coverage in recent decades, the objectives of many Global Vaccine Action Plans have not been met. For many countries, the COVID-19 pandemic was a further impediment to achieving their target vaccination coverage, as they had to shift their focus to the introduction of COVID-19…
Context Global health crises are on the rise, especially those caused by infectious disease outbreaks, and pose a serious threat to health and well-being. WHO estimates that up to 10 million lives could be saved every year if access to safe and effective medicines and vaccines were improved. As a…
Context The COVID-19 pandemic revealed the need to increase laboratory capacities in many countries, including the Democratic Republic of Sao Tome and Principe. Since 2020, the BNITM has been supporting the country’s Ministry of Health in implementing laboratory diagnostics for SARS-CoV-2 under the SToP-CoV project. Nevertheless, there is still room…
Context Madagascar is facing significant challenges in its health care system, due to the high prevalence of infectious diseases in the country, particularly neglected tropical diseases (NTDs). Many of these diseases occur simultaneously and have chronic manifestations, imposing a huge burden on the population. It is therefore vitally important to…
Context Antimicrobial resistance (AMR) is a global problem that jeopardises the successful treatment and control of infectious diseases. Each year, millions of people – particularly children under the age of five who are the most vulnerable to resistant pathogens – die of AMR-related infections. Effective surveillance systems are key to…